A decade of experience emphasizes that testing for Y microdeletions is essential in American men with azoospermia and severe oligozoospermia
To access this article, please choose from the options below
P.J.S. has nothing to disclose. P.M. has nothing to disclose. A.M. has nothing to disclose. M.B.M. has nothing to disclose. P.N.S. has nothing to disclose. D.A.P. has nothing to disclose.
PII: S0015-0282(09)03685-1
doi:10.1016/j.fertnstert.2009.09.006
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

